Ivascular Review

August 2026

Ivascular Review (August 2026)

Catheters for the treatment of endovascular stenotic, restenotic or occlusive lesions, endovascular injuries and ischemic stroke.

$134MRevenue

282Employees

21%Growth

$134M

Revenue

282

Employees

21%

Growth

Estimated Revenue

$134M

Total Employees

282

Employee Growth

21%

Industry

Location

About

Catheters for the treatment of endovascular stenotic, restenotic or occlusive lesions, endovascular injuries and ischemic stroke.

Global Rank

N/A

Ivascular's estimated revenue is $134M.

Catheters for the treatment of endovascular stenotic, restenotic or occlusive lesions, endovascular injuries and ischemic stroke.

Company	Revenue	Employees	Growth	Funding
iVascular	$134.4M	282	20.3%	N/A
otra empresa	$62.0M	148	30.5%	N/A
Diagnostica Longwood	$39.7M	104	13.0%	N/A
AMBULANCIAS TENORIO E HIJOS SL	$72.9M	174	74.0%	N/A
Ovoclinic	$73.6M	176	31.0%	N/A
ÅKRN Now Part of NAMSA	$0.8M	4	-66.7%	N/A
Hoya Lens Iberia	$33.6M	88	85.0%	N/A
Sysmex España	$87.3M	208	6.7%	N/A
Miranza	$100.7M	240	30.3%	N/A